Should an individual become diagnosed with pelvic organ prolapse or stress urinary incontinence, one of the most common treatment options is to utilize a pelvic/bladder support product, such as a sling. One of the most popular products used is what is known as trans-vaginal mesh; this is an implantable plastic device that is used along with stitches to support the organs in a woman’s pelvic region. During surgery, the mesh is placed against the vaginal wall to provide support to the damaged area.
Over the past few years, serious health concerns have emerged regarding the implantation of trans-vaginal mesh and pelvic/bladder support devices. Recent studies have demonstrated harrowing results. In fact, it has been reported that more than 15% of women who underwent this surgery have experienced what has been known as “erosion” which results in the skin splitting and the mesh used during the surgical procedure to begin to protrude. Beyond this, as the body begins to heal from the procedure, the scar tissue could provide complications that could make it difficult, if not impossible, to remove it from the woman – lengthening the suffering.
Over the past few years, the FDA has received over 1500 reports regarding a failed procedure by patients who have had surgery to implant the pelvic/bladder support system. At Hecht Kleeger & Damashek, P.C., our New York City injury lawyers are well aware of these FDA warnings, and have extended our professional support to victims accordingly. Some of the most common failures that have been reported have included the following:
While reviewing the literature regarding these procedures, it was discovered by the FDA that those who chose this over the more traditional methods experienced a significant increase in the risks that they faced. It was noted that while this improved simple anatomy, it did not actually do anything to go beyond what could be achieved without the mesh.
Due to this, the FDA has released several warnings and has even retroactively strengthened previous ones. This included a recommendation that physicians fully inform their patents about the risks associated with surgeries of this nature. They are also to monitor all patients and immediately remove the mesh should it be determined that the patient is suffering from adverse side effects. It has been recommended that this procedure be considered “experimental” and to be used unless as a last resort as the benefits did not outweigh the hazards and risk of serious injury.
At Hecht Kleeger & Damashek, P.C., we recognize that dealing with product liability cases of this nature is not simple. The initial procedure was undoubtedly complicated and painful; having to deal with adverse side effects after the fact can be physical, emotional and financial stressful. For this reason, should you choose to file a transvaginal mesh lawsuit and work with a New York City injury lawyer from our firm, you will be able to rest easier knowing that you have an experienced advocate on your side who is fully prepared to help you evaluate your claim and determine the best course of action.